RJA
VTGN icon

Raymond James & Associates’s VistaGen Therapeutics VTGN Stock Holding History

Raymond James & Associates’s Portfolio VTGN Stock Details VTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,000
Closed -$52.4K – 3895
2023
Q3 		$52.4K Buy
+10,000
New +$52.4K ﹤0.01% 3636